The '''Pan-African Society of Hypertension(PASH,Inc.)''' is an international organization with the objective to provide a stable and organized African platform for scientific exchange in [[arterial hypertension]]. The society was created in 2010 on the initiative of [[Marc Twagirumukiza]]. The official membership is obtained after registration.

== Meetings ==
The society organizes bi-annual meetings in different African cities<ref>[http://www.pash-onweb.com/indexconf.php PASH Inc Annual Meetings]</ref> as well as [[summer school]]s.<ref>[http://www.pash-onweb.com/indexconf.php PASH Inc. Summer School of Hypertension]</ref>

==Research activities==
The PASH Inc. areas of research activities are illustrated by the different task forces:
*Task force 1: Mapping the arterial hypertension prevalence on the continent and make predictions for near future.
*Task force 2: Mapping the prevalence of arterial hypertension risk factors and related CV risk factors
**II-a Traditionally risk factors : which covers the risk factors like the [[sedentary lifestyle]],<ref name="pmid17148735">{{cite journal |author=Kyrou I, Chrousos GP, Tsigos C |title=Stress, visceral obesity, and metabolic complications |journal=Annals of the New York Academy of Sciences |volume=1083 |issue= |pages=77–110 |year=2006 |month=November |pmid=17148735 |doi=10.1196/annals.1367.008}}</ref> smoking, and stress.  This list includes also other factors like the [[aging]],<ref>{{cite journal |author=Kosugi T, Nakagawa T, Kamath D, Johnson RJ |title=Uric acid and hypertension: an age-related relationship? |journal=J Hum Hypertens |volume=23 |issue=2 |pages=75–6 |year=2009 |month=February |pmid=18754017 |doi=10.1038/jhh.2008.110 |url=}}</ref> [[renin]] related patterns,<ref name="pmid17903324">{{cite journal |author=Segura J, Ruilope LM |title=Obesity, essential hypertension and renin-angiotensin system |journal=Public Health Nutrition |volume=10 |issue=10A |pages=1151–5 |year=2007 |month=October |pmid=17903324 |doi=10.1017/S136898000700064X}}</ref> or [[sympathetic system|sympathetic]] nervous system related issues.<ref name="hypertension9">{{cite journal |author=Rahmouni K, Correia ML, Haynes WG, Mark AL |title=Obesity-associated hypertension: new insights into mechanisms |journal=Hypertension |volume=45 |issue=1 |pages=9–14 |year=2005 |month=January |pmid=15583075 |doi=10.1161/01.HYP.0000151325.83008.b4 |url=}}</ref> 
**II-b: Arterial stiffness
**II-c: Genetic factors: which covers all potential [[genetic mutations]],<ref name="pmid16754793">{{cite journal |author=Dickson ME, Sigmund CD |title=Genetic basis of hypertension: revisiting angiotensinogen |journal=Hypertension |volume=48 |issue=1 |pages=14–20 |year=2006 |month=July |pmid=16754793 |doi=10.1161/01.HYP.0000227932.13687.60}}</ref> and family history of hypertension related research.<ref name="pmid16719248">{{cite journal |author=Luma GB, Spiotta RT |title=Hypertension in children and adolescents |journal=[[Am Fam Physician]] |volume=73 |issue=9 |pages=1558–68 |year=2006 |month=May |pmid=16719248 |doi= |url= |issn= |accessdate=2009-06-01}}</ref>
**II-d: Nutritional and metabolic risk factors : which covers all components of [[metabolic syndrome|syndrome X]] (or the [[metabolic syndrome]]), like the [[Insulin resistance]],<ref name="pmid17903324"/><ref name="pmid12364344">{{cite journal |author=Sorof J, Daniels S |title=Obesity hypertension in children: a problem of epidemic proportions |journal=Hypertension |volume=40 |issue=4 |pages=441–7 |year=2002 |month=October |pmid=12364344 |doi= 10.1161/01.HYP.0000032940.33466.12|url=http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=12364344 |issn= |accessdate=2009-06-03}}</ref> [[obesity]],<ref name="pmid15579059">{{cite journal |doi=10.2174/1381612043382855 |author=Wofford MR, Hall JE |title=Pathophysiology and treatment of obesity hypertension |journal=Current Pharmaceutical Design |volume=10 |issue=29 |pages=3621–37 |year=2004 |pmid=15579059 |url=http://www.bentham-direct.org/pages/content.php?CPD/2004/00000010/00000029/0007B.SGM}}</ref><ref name=HaslamJames>{{cite journal |author=Haslam DW, James WP |title=Obesity |journal=Lancet |volume=366 |issue=9492 |pages=1197–209 |year=2005 |pmid=16198769 |doi=10.1016/S0140-6736(05)67483-1}}</ref> [[Salt#Health effects|salt (sodium) sensitivity]],<ref name="pmid17686383">{{cite journal |author=Lackland DT, Egan BM |title=Dietary salt restriction and blood pressure in clinical trials |journal=[[Curr. Hypertens. Rep.]] |volume=9 |issue=4 |pages=314–9 |year=2007 |month=August |pmid=17686383 |doi= 10.1007/s11906-007-0057-8|url= |issn= |accessdate=2009-06-01}}</ref> [[alcohol]] intake,<ref name="pmid19480755">{{cite journal |doi=10.1016/S1885-5857(09)72223-6 |author=Djoussé L, Mukamal KJ |title=Alcohol consumption and risk of hypertension: does the type of beverage or drinking pattern matter? |journal=Revista Española De Cardiología |volume=62 |issue=6 |pages=603–5 |year=2009 |month=June |pmid=19480755 |url=http://www.revespcardiol.org/cardio/62/603}}</ref> and [[hypovitaminosis D|vitamin D deficiency]].<ref name="pmid19444937">{{cite journal |author=Tuohimaa P |title=Vitamin D and aging |journal=[[The Journal of Steroid Biochemistry and Molecular Biology]] |volume=114 |issue=1-2 |pages=78–84 |year=2009 |month=March |pmid=19444937 |doi= 10.1016/j.jsbmb.2008.12.020|url= |issn= |accessdate=2009-06-02}}</ref><ref>{{cite journal |author=Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF |title=Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? |journal=J. Am. Coll. Cardiol. |volume=52 |issue=24 |pages=1949–56 |year=2008 |pmid=19055985 |doi=10.1016/j.jacc.2008.08.050 }}</ref> as well as all potassium deficiency related risk factors([[hypokalemia]]),<ref name="pmid17148735"/> 
**II-e: The new risk factors and experimental discovery : which covers the new or still debatable or under discovery factors like [[low birth weight]],<ref name="pmid18700545">{{cite journal |author=Uchiyama M |title=[Mild hypertension in children] |language=Japanese |journal=[[Nippon Rinsho]] |volume=66 |issue=8 |pages=1477–80 |year=2008 |month=August |pmid=18700545 |doi= |url= |issn= |accessdate=2009-06-01}}</ref> and others.
*Task force 3: Prevention and intervention research in primary care which covers all health systems, policy, and primary care research.
*Task force 4: Treatment strategies for hypertension on African continent (guidelines, clinical trials - Cost effectiveness- Access to medicines-EBM, etc.)
*Task force 5: Community advocacy, education and communication

==References==
{{Reflist}}

==External links==
* {{Official website|http://www.pash-onweb.org}}

[[Category:Africa]]
[[Category:Medical associations]]